Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07456852) titled 'Vasodilator Therapy With Isosorbide Mononitrate or Diltiazem to Reduce Vasotoxicity in Patients With Gastrointestinal Cancer Receiving Fluoropyrimidine Therapy' on March 2.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Sequential Assignment. Primary purpose: Treatment. Masking: Triple (Participant, Investigator, Outcomes Assessor).
Primary Sponsor: Mayo Clinic
Condition:
Malignant Digestive System Neoplasm
Intervention:
Procedure: Biospecimen Collection
Drug: Capecitabine
Drug: Diltiazem Hydrochloride
Procedure: Electrocardiogram
Drug: Fluorouracil
Device: Holter Monitori...